Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 4, 2002, Pages 400-405

  Contreras, Carmen E ^a   Cortese, Joseph F ^a   Caraballo, Alejandro ^a   Plowe, Christopher V ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; FOLIC ACID ANTAGONIST;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD ANALYSIS; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PROTOZOAL GENETICS; SCHOOL CHILD; VENEZUELA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036806981     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.400     Document Type: Article

References (32)

1. Butler WP, Roberts DR, 2000. Malaria in the Americas: A model of reemergence. Mil Med 165: 897-902.
2. Pan American Health Organization, 2001. Situation of malaria in the Americas. Epidemiol Bull 22: 10-16.
3. Sawyer D, 1993. Economic and social consequences of malaria in new colonization projects in Brazil. Soc Sci Med 37: 1131-1136.
4. Witzig R, Ascencios M, 1999. The road to indigenous extinction: Case study of resource exportation, disease importation, and human rights violations against the Urarina in the Peruvian Amazon. Health Hum Rights 4: 60-81.
5. Sawyer DR, 1992. Malaria and the Environment. Brasilia: Instituto Sociedade Populacao e Natureza. Documento de Trabalho, 1-37.
6. Bouma MJ, Dye C, 1997. Cycles of malaria associated with El Niño in Venezuela. JAMA 278: 1772-1774.
7. Maberti S, 1960. Desarrollo de resistencia a la pirimetamina. Arch Ven Med Trop Parasitol Med 3: 329-359.
8. Gabaldon A, Berti AL, 1954. The first large area in the tropical zone to report malaria eradication: North-central Venezuela. Am J Trop Med Hyg 3: 793-807.
9. Godoy GA, Volcan GS, Guevara R, Medrano C, Castro J, Texeira A, 1977. Venezuelan strains of Plasmodium falciparum resistant to sulfa and pyrimethamine as demonstrated by an in vitro test. Rev Latinoam Microbiol 19: 229-231.
10. Espinal CA, Cortes GT, Guerra P, Arias AE, 1985. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 34: 675-680.
11. Alecrim M, Dourado H, Alecrim MG, Passos LF, Wanssa E, Albuquerque B, 1982. In vivo resistance of Plasmodium falciparum to a combination of sulfadoxine plus pyrimethamine at RIII level in Amazonas, Brazil. Rev Inst Med Trop Sao Paulo 24 (Suppl 6): 52-53.
12. Plowe CV, 2001. Folate Antagonists and Mechanisms of Resistance. Rosenthal PJ, ed. Antimalarial Chemotherapy. Totowa, NJ: Humana Press, 173-190.
13. Cortese JF, Plowe CV, 1998. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Mol Biochem Parasitol 94: 205-214.
14. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine- sulfadoxine use and resistance. J Infect Dis 176: 1590-1596.
15. Watkins WM, Maberu PA, Winstanley PA, Plowe CV, 1997. The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today 13: 459-464.
16. Watkins WM, Maberu PA, Winstanley PA, Plowe CV, 1999. More on the efficacy of antifolate antimalarial combinations in Africa. Parasitol Today 15: 131-132.
17. Kublin KG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RAG, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum Malaria. J Infect Dis 185: 380-385.
18. Wellems TE, Plowe CV, 2001. Chloroquine-resistant malaria. J Infect Dis 184: 770-776.
19. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock DA, Zimmerman PA, 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci USA 98: 12689-12694.
20. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 257-263.
21. Urdaneta L, Plowe C, Goldman I, Lal AA, 1999. Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela. Am J Trop Med Hyg 61: 457-462.
22. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
23. Vieira PP, das Gracas AM, da Silva LH, Gonzalez-Jimenez I, Zalis MG, 2001. Analysis of the PfCRT K76T mutation in Plasmodium falciparum isolates from the Amazon region of Brazil. J Infect Dis 183: 1832-1833.
24. Cortese JF, Caraballo A, Contreras CE, Plowe CV, 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186: 999-1006.
25. Su X, Wellems TE, 1996. Toward a high resolution Plasmodium falciparum linkage map: Polymorphic markers from hundreds of simple sequence repeats. Genomics 33: 430-444.
26. Urdaneta L, Lal A, Barnabe C, Oury B, Goldman I, Ayala FJ, Tibayrenc M, 2001. Evidence for clonal propagation in natural isolates of Plasmodium falciparum from Venezuela. Proc Natl Acad Sci USA 98: 6725-6729.
27. Vasconcelos KF, Plowe CV, Fontes CJ, Kyle D, Wirth DF, Pereira da Silva LH, Zalis MG, 2000. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem Inst Oswaldo Cruz 95: 721-728.
28. Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV, 1998. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351: 1629-1630.
29. Caraballo A, Rodriguez-Acosta A, 1999. Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela. Am J Trop Med Hyg 61: 120-124.
30. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF, 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403: 906-909.
31. Djimde A, Doumbo OK, Steketee RW, Plowe CV, 2001. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358: 890-891.
32. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W, 2001. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358: 1218-1223.